369 related articles for article (PubMed ID: 27632783)
1. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the multiplexed quantification of etravirine, maraviroc, raltegravir, and rilpivirine in human plasma and tissue.
Parsons TL; Marzinke MA
J Pharm Biomed Anal; 2016 Nov; 131():333-344. PubMed ID: 27632783
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of etravirine, maraviroc and raltegravir in pigtail macaque plasma, vaginal secretions and vaginal tissue using a LC-MS/MS assay.
Blakney AK; Jiang Y; Whittington D; Woodrow KA
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1025():110-8. PubMed ID: 27236000
[TBL] [Abstract][Full Text] [Related]
3. Development and bioanalytical validation of a liquid chromatographic-tandem mass spectrometric (LC-MS/MS) method for the quantification of the CCR5 antagonist maraviroc in human plasma.
Emory JF; Seserko LA; Marzinke MA
Clin Chim Acta; 2014 Apr; 431():198-205. PubMed ID: 24561264
[TBL] [Abstract][Full Text] [Related]
4. Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysis.
Parsons TL; Emory JF; Seserko LA; Aung WS; Marzinke MA
J Pharm Biomed Anal; 2014 Sep; 98():407-16. PubMed ID: 25005891
[TBL] [Abstract][Full Text] [Related]
5. Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.
Hummert P; Parsons TL; Ensign LM; Hoang T; Marzinke MA
J Pharm Biomed Anal; 2018 Apr; 152():248-256. PubMed ID: 29433097
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots.
Weld ED; Parsons TL; Gollings R; McCauley M; Grinsztejn B; Landovitz RJ; Marzinke MA
J Pharm Biomed Anal; 2023 May; 228():115307. PubMed ID: 36842333
[TBL] [Abstract][Full Text] [Related]
7. Validation and implementation of an ultrasensitive liquid chromatographic-tandem mass spectrometric (LC-MS/MS) assay for dapivirine quantitation in breast milk.
Manohar M; Marzinke MA
Clin Biochem; 2020 Aug; 82():66-72. PubMed ID: 31843664
[TBL] [Abstract][Full Text] [Related]
8. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
[TBL] [Abstract][Full Text] [Related]
9. Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology.
Djerada Z; Feliu C; Tournois C; Vautier D; Binet L; Robinet A; Marty H; Gozalo C; Lamiable D; Millart H
J Pharm Biomed Anal; 2013 Dec; 86():100-11. PubMed ID: 23995753
[TBL] [Abstract][Full Text] [Related]
10. Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds.
Else L; Watson V; Tjia J; Hughes A; Siccardi M; Khoo S; Back D
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1455-65. PubMed ID: 20427248
[TBL] [Abstract][Full Text] [Related]
11. Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma.
Schauer AP; Sykes C; Cottrell ML; Imaz A; Podzamczer D; Kashuba AD
J Pharm Biomed Anal; 2022 Oct; 220():115010. PubMed ID: 36030752
[TBL] [Abstract][Full Text] [Related]
12. A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine.
Fayet A; Béguin A; Zanolari B; Cruchon S; Guignard N; Telenti A; Cavassini M; Günthard HF; Buclin T; Biollaz J; Rochat B; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1057-69. PubMed ID: 19332396
[TBL] [Abstract][Full Text] [Related]
13. Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry.
Ter Heine R; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
J Pharm Biomed Anal; 2009 Feb; 49(2):393-400. PubMed ID: 19059744
[TBL] [Abstract][Full Text] [Related]
14. The development and validation of a turbulent flow-liquid chromatography-tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum.
Petrides AK; Moskowitz J; Johnson-Davis KL; Jannetto PJ; Langman LJ; Clarke W; Marzinke MA
Clin Biochem; 2014 Oct; 47(15):73-9. PubMed ID: 25087976
[TBL] [Abstract][Full Text] [Related]
15. A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
Aouri M; Calmy A; Hirschel B; Telenti A; Buclin T; Cavassini M; Rauch A; Decosterd LA
J Mass Spectrom; 2013 May; 48(5):616-25. PubMed ID: 23674286
[TBL] [Abstract][Full Text] [Related]
16. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
Li W; Lin H; Fu Y; Flarakos J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography-tandem mass spectrometric assay for the non-nucleoside reverse transcriptase inhibitor rilpivirine in human plasma.
Burugula L; Pilli NR; Makula A; Lodagala DS; Kandhagatla R
Biomed Chromatogr; 2013 Feb; 27(2):172-8. PubMed ID: 22729755
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action.
West RE; Oberly PJ; Saylor AJ; Riddler SA; Nolin TD; Devanathan AS
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124164. PubMed ID: 38823149
[TBL] [Abstract][Full Text] [Related]
19. Development, validation and clinical implementation of a UPLC-MS/MS bioanalytical method for simultaneous quantification of cabotegravir and rilpivirine E-isomer in human plasma.
Bevers LAH; van Ewijk-Beneken Kolmer EWJ; Te Brake HML; Burger DM
J Pharm Biomed Anal; 2024 Jan; 238():115832. PubMed ID: 37976991
[TBL] [Abstract][Full Text] [Related]
20. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
